NEW YORK, March 08, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against BioNTech SE ("BioNTech" or the "Company") (NASDAQ:BNTX) in the United States District Court for the Central District of California on behalf of all persons and entities who purchased or otherwise acquired BioNTech securities between March 30, 2022 and October 13, 2023, both dates inclusive (the "Class Period"). Investors have until March 12, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
Click here to participate in the action.
According to the filed complaint, throughout the ...